In this episode of ATTD 2026 Conference Catch-Up, we dive into What Else Is New? Featuring the latest advancements in the treatment and monitoring of Type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Adjunctive Treatment with GLP/GIPS for Patients with Type 1 Diabetes: Consensus Report and Guidelines for Safer Use – Prof. Satish Garg An International Consensus on Screening and Monitoring Early-stage Type 1 Diabetes: A Roadmap to European Implementation – Online First Release – Dr. Sufyan Hussain This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to stay updated on the newest consensus guidelines and the future of screening and treatment strategies for Type 1 diabetes. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related